What is SeqMatic?
SeqMatic specializes in providing comprehensive sequencing solutions, including DNA, RNA, and single-cell sequencing, alongside histopathology and bioinformatics services. Operating from its CLIA-licensed and CAP-accredited laboratory in Fremont, California, the company is committed to delivering fast turnaround times and personalized service. SeqMatic's science-first approach ensures high-quality data for a global clientele of research institutions and corporations, positioning it as a key player in the genomics and multi-omics landscape.
How much funding has SeqMatic raised?
SeqMatic has raised a total of $300K across 2 funding rounds:
Debt
$150K
Debt
$150K
Debt (2020): $150K with participation from PPP
Debt (2021): $150K led by PPP
What's next for SeqMatic?
With its recent strategic investment and substantial total funding, SeqMatic is poised for accelerated growth and innovation. The company is likely to leverage this capital to enhance its service offerings, expand its technological capabilities, and potentially broaden its market reach. This late-stage funding suggests a focus on scaling operations, optimizing its bioinformatics platforms, and solidifying its competitive advantage in the rapidly evolving field of genomic services. Future developments may include advancements in single-cell analysis and integrated multi-omics solutions.
See full SeqMatic company page
